Alogliptin Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Alogliptin Alogliptin Benzoate VL5900001View CAS 850649-62-6
Alogliptin Alogliptin Benzoate Dimer Impurity VL5900040View CAS 1268836-55-0
Alogliptin Alogliptin Benzoate S-Isomer (HCl Salt) VE009388View
Alogliptin Alogliptin Dimer Impurity VE009676View
Alogliptin Alogliptin Hydroxy Impurity VE007844View
Alogliptin Alogliptin Impurity 1 VL5900022View CAS 2468009-93-8
Alogliptin Alogliptin Impurity 11 VL5900005View CAS 1618644-32-8
Alogliptin Alogliptin Impurity 12 VL5900006View CAS 2089611-85-6
Alogliptin Alogliptin Impurity 13 VL5900007View CAS 865758-98-1
Alogliptin Alogliptin Impurity 14 VL5900008View CAS 1820685-30-0
Alogliptin Alogliptin Impurity 15 VL5900010View CAS 1108731-49-2
Alogliptin Alogliptin Impurity 18 VL5900013View CAS 1430222-09-5
Alogliptin Alogliptin Impurity 2 VL5900029View
Alogliptin Alogliptin Impurity 22 VL5900017View CAS 655-63-0
Alogliptin Alogliptin Impurity 23 VL5900018View CAS 1618644-29-3
Alogliptin Alogliptin Impurity 24 VL5900019View CAS 1430222-06-2
Alogliptin Alogliptin Impurity 25 VL5900020View CAS 1246610-72-9
Alogliptin Alogliptin Impurity 26 VL5900021View CAS 865759-10-0
Alogliptin Alogliptin Impurity 27 VL5900023View CAS 865758-95-8
Alogliptin Alogliptin Impurity 28 VL5900024View CAS 865758-96-9
Alogliptin Alogliptin Impurity 29 VL5900025View CAS 1246610-74-1
Alogliptin Alogliptin Impurity 3 VL5900030View CAS 1108732-05-3
Alogliptin Alogliptin Impurity 30 VL5900026View CAS 2276316-91-5
Alogliptin Alogliptin Impurity 35 VL5900043View CAS 872414-52-3
Alogliptin Alogliptin Impurity 5 VL5900033View CAS 1338677-76-1
Alogliptin Alogliptin N-Acetylated Metabolite M-II VL5900009View
Alogliptin Alogliptin N-Des(cyanobenzyl) Impurity VL5900045View
Alogliptin Alogliptin N-Formyl Carbamoyl Impurity VL5900046View
Alogliptin 2, 4, 6-Trichloro Pyrimidine VE007845View CAS 3764-01-0
Alogliptin 2-(Bromomethyl)benzonitrile VL5900042View CAS 22115-41-9
Alogliptin 3-Amino Piperidine Impurity VL5900036View CAS 309956-78-3
Alogliptin 3-Amino Piperidine impurity VL5900037View CAS 54012-73-6
Alogliptin 4-Fluoro-2-methylbenzonitrile VL5900039View CAS 147754-12-9
Alogliptin 6-Chloro-3-methyluracil VL5900041View CAS 4318-56-3
Alogliptin (R)-3-Aminopiperidine Dihydrochloride VL5900038View CAS 334618-23-4

Alogliptin Related Compound

Alogliptin reduces blood sugar levels in type 2 diabetic patients combined with diet and exercise.

References

  • Alogliptin: MedlinePlus Drug Information.” Medlineplus.gov, 2016, medlineplus.gov/druginfo/meds/a613026.html#:~:text=Alogliptin%20is%20in%20a%20class,body%20to%20control%20blood%20sugar. Accessed 9 Feb. 2023.
  • Alogliptin: Uses, Interactions, Mechanism of Action | DrugBank Online.” Drugbank.com, DrugBank, 2013,go.drugbank.com/drugs/DB06203. Accessed 9 Feb. 2023. ‌

FAQ’s

What type of drug is alogliptin?

Alogliptin belongs to a family of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. It regulates blood sugar by raising the quantity of insulin in the body.

What is alogliptin used to treat?

Alogliptin is a diabetes treatment medication. Type 2 diabetes is a condition in which the body does not produce enough insulin or the insulin produced does not function correctly. This might result in elevated blood sugar levels (hyperglycaemia).

What is the mechanism of action of alogliptin?

Alogliptin inhibits DPP-4, which typically degrades the incretins glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1. ( GLP-1). DPP-4 inhibition increases the quantity of active plasma incretins, which aids in glycemic management.

Request a quote

1108731-49-2: Alogliptin Impurity 15

1108731-49-2: Alogliptin Impurity 15
Catalogue No.

VL5900010
CAS No.

1108731-49-2
Molecular Formula

C20H23N5O3
Molecular Weight

381.44 g/mol
Parent drug

Alogliptin
IUPAC Name

(R)-N-(1-(3-(2-cyanobenzyl)-1-methyl-2, 6-dioxo-1, 2, 3, 6-tetrahydropyrimidin-4-yl)piperidin-3-yl)acetamide
Synonyms

N/A
References

Dineen, Laura, et al. “Alogliptin (Nesina) for Adults with Type-2 Diabetes.” Pharmacy and Therapeutics, vol. 39, no. 3, 1 Mar. 2014, pp. 186–202, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4005122/.
Status

In-stock
ListName

Alogliptin Impurity 15
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url